These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions. Lu S; Zhang J J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894 [TBL] [Abstract][Full Text] [Related]
4. [The pharmacological effect of allosteric regulation at GPCR heterodimer]. Zhang N; Chen J; Gong L; Liu LL; Bai B Sheng Li Ke Xue Jin Zhan; 2013 Apr; 44(2):93-8. PubMed ID: 23847918 [TBL] [Abstract][Full Text] [Related]
5. "Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu Hellyer SD; Albold S; Wang T; Chen ANY; May LT; Leach K; Gregory KJ Mol Pharmacol; 2018 May; 93(5):504-514. PubMed ID: 29514854 [TBL] [Abstract][Full Text] [Related]
6. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target. Janero DR; Thakur GA Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124 [TBL] [Abstract][Full Text] [Related]
7. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development. Hurevich M; Talhami A; Shalev DE; Gilon C Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995 [TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation of G protein-coupled receptor signaling. Shen S; Zhao C; Wu C; Sun S; Li Z; Yan W; Shao Z Front Endocrinol (Lausanne); 2023; 14():1137604. PubMed ID: 36875468 [TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery. Persechino M; Hedderich JB; Kolb P; Hilger D Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587 [TBL] [Abstract][Full Text] [Related]
10. Strategies for the identification of allosteric modulators of G-protein-coupled receptors. Burford NT; Watson J; Bertekap R; Alt A Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747 [TBL] [Abstract][Full Text] [Related]
11. Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5. Bian Y; Feng Z; Yang P; Xie XQ AAPS J; 2017 Jul; 19(4):1235-1248. PubMed ID: 28560482 [TBL] [Abstract][Full Text] [Related]
12. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery. Slosky LM; Caron MG; Barak LS Trends Pharmacol Sci; 2021 Apr; 42(4):283-299. PubMed ID: 33581873 [TBL] [Abstract][Full Text] [Related]
13. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs. Bartuzi D; Kaczor AA; Matosiuk D Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568 [TBL] [Abstract][Full Text] [Related]
14. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor. Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651 [TBL] [Abstract][Full Text] [Related]
18. The role of water and protein flexibility in the structure-based virtual screening of allosteric GPCR modulators: an mGlu Orgován Z; Ferenczy GG; Keserű GM J Comput Aided Mol Des; 2019 Sep; 33(9):787-797. PubMed ID: 31542869 [TBL] [Abstract][Full Text] [Related]
19. Allosteric modulators of G-protein-coupled receptors. May LT; Christopoulos A Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102 [TBL] [Abstract][Full Text] [Related]
20. Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery. Bian Y; Jun JJ; Cuyler J; Xie XQ Eur J Med Chem; 2020 Nov; 206():112690. PubMed ID: 32818870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]